Latest Regulatory Progress News

Page 15 of 32
Enova Mining reports promising exploration results across its Brazilian and Australian projects, highlighting high-grade rare earth element assays and advancing metallurgical testing and regulatory approvals.
Maxwell Dee
Maxwell Dee
31 July 2025
4DMedical has landed a $10 million strategic investment from Pro Medicus, aimed at accelerating its commercial growth and advancing its CT – VQ™ technology towards FDA clearance in the US.
Ada Torres
Ada Torres
31 July 2025
Larvotto Resources delivers a robust Definitive Feasibility Study for its Hillgrove Antimony-Gold Project, backed by $165 million in fresh funding and regulatory approvals, targeting production in Q2 2026.
Maxwell Dee
Maxwell Dee
31 July 2025
Aspire Mining Limited has refined its Ovoot Coking Coal Project development plans to reduce upfront capital expenditure, progressing towards mining commencement in Q4 2025 amid positive market feedback and advancing infrastructure contracts.
Maxwell Dee
Maxwell Dee
31 July 2025
Northern Minerals reports strong progress on its Browns Range Heavy Rare Earths Project with key regulatory approvals, promising exploration results, and near-completion of its Definitive Feasibility Study amid tightening global supply.
Maxwell Dee
Maxwell Dee
31 July 2025
Medical Developments International (MVP) reports positive operating cash flow in H2 FY25, driven by strong Penthrox sales and strategic distribution shifts in Europe. The company eyes further growth amid regulatory progress and efficiency gains.
Ada Torres
Ada Torres
31 July 2025
HALO Technologies reports $3.54 million in Q2 revenue with rising subscription income, progressing UK expansion pending FCA approval, and a $6.75 million capital raise nearing completion.
Claire Turing
Claire Turing
31 July 2025
Beetaloo Energy Australia Limited has completed a $35 million capital raise and successfully finished hydraulic stimulation of its Carpentaria-5H well, setting the stage for production expected in 2026. Traditional Owner consent and strong liquidity underpin the company’s next development phase.
Maxwell Dee
Maxwell Dee
31 July 2025
Neurotech International reports encouraging Phase I human pharmacokinetic results for its pediatric cannabinoid drug NTI164, alongside published clinical trial data in Rett Syndrome and key regulatory progress in the US and Australia.
Ada Torres
Ada Torres
31 July 2025
Po Valley Energy reports steady gas production from its Podere Maiar-1 field and progresses permitting for new wells in Italy, supported by robust cash reserves and ongoing stakeholder engagement.
Maxwell Dee
Maxwell Dee
31 July 2025
Echelon Resources finalised its EP145 acquisition and reported a slight dip in production volumes, while Amadeus Basin receipts surged 24% thanks to new wells. The company maintains a strong cash position and is actively reshaping its portfolio for future growth.
Maxwell Dee
Maxwell Dee
31 July 2025
Silver Mines Limited progresses regulatory approvals for its flagship Bowdens Silver Project in NSW while acquiring promising US assets, enhancing its exploration pipeline with minimal upfront costs.
Maxwell Dee
Maxwell Dee
31 July 2025